Retina

Latest News

Exonate announces CLEAR-DE trial for EXN407
Exonate announces CLEAR-DE trial for EXN407

July 30th 2025

Exonate initiates a phase 2b trial for EXN407, a groundbreaking eye drop treatment for diabetic retinopathy

The retina undergoing fundus imaging. Concept image for retinal imgaging, OCT, CA, cardiac angiography, optical coherence tomography and biomarkers. Image credit: ©Panama – stock.adobe.com
Biomarkers of microvascular retinal perfusion indicating coronary heart disease

July 29th 2025

A photo of the European Medicines Agency (EMA) headquarters. Concept image for Alteogen aflibercept biosimilar approval, Committee for Medicinal Products for Human Use  CHMP positive opinion for EYLUXVI. Image credit: ©Ogulcan Aksoy - SCA – stock.adobe.com
Alteogen receives positive CHMP opinion for aflibercept biosimilar EYLUXVI

July 28th 2025

A brain and a fungus mushroom both depicted in illustration. Concept image for fungal infection and diabetic eye disease. Image credit: ©Anson – stock.adobe.com  – generated with AI
Fungal infection and vision impact in patients with diabetic eye disease

July 25th 2025

Two empty medical syringes on a gradient blue and white surface. Concept image for methotrexate for intravitreal injection for retinitis pigmentosa, European Medicines Agency (EMA) orphan drug designation announcement. Image credit: ©cassis – stock.adobe.com
EMA grants orphan designation to ADX-2191 (Aldeyra Therapeutics) for inherited retinal dystrophies

July 24th 2025

Video Series
Video Interviews
Podcasts
PHOTON Results and Their Relation to DME Patients in Your Practice
PULSAR Results and Their Relation to nAMD Patients in Your Practice
Latest CME Events & Activities

More News

© 2025 MJH Life Sciences

All rights reserved.